Registry of Cardiovascular Disease Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

110000 participants

Study Classification

OBSERVATIONAL

Study Start Date

1998-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A computerized registry of cardiovascular disease patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify cardiovascular disease patients and to follow the courses of their illnesses and risk factors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases

NCT04844944

Heart Failure Coronary Artery Disease Atrial Fibrillation

RECRUITING

Assessment of Myocardial Viability Using Multidetector Computed Tomography

NCT00285064

Myocardial Infarction

COMPLETED NA

Cardio Pulmonary Exercise Testing in Patients Post the Fontan Palliation in Comparison With Patients With Repaired Congenital Heart Disease and Healthy Volunteers.

NCT02659462

Fontan Palliation Congenital Heart Disease

UNKNOWN

The Israeli MGuard Registry

NCT00922337

Ischemic Heart Disease Acute Coronary Syndrome Acute Myocardial Infarction

COMPLETED

Recording of Heart Signals From the Chest Wall

NCT00661934

Cardiac Malfunction

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.

The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Heart Disease Congestive Heart Failure Peripheral Vascular Disease Cerebrovascular Disease Atrial Fibrillation Cerebrovascular Atherosclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardiovascular Disease Patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical Diagnosis of the following:

Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis.

* Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes

Exclusion Criteria

* patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication
* Patients whose primary physician reported that the patient is CHD-free providing adequate medical records

Eligible Sex

ALL

Accepts Healthy Volunteers

No